Status:

COMPLETED

Study on Regenerative Treatment of Intra-bony Defects

Lead Sponsor:

Technische Universität Dresden

Conditions:

Periodontal Disease

Periodontal Attachment Loss

Eligibility:

All Genders

18-70 years

Phase:

PHASE4

Brief Summary

The aim of this investigation is to determine whether a synthetic hydroxyapatite is as effective as an enamel matrix protein for periodontal regeneration in patients who have intra-bony periodontal de...

Detailed Description

Regeneration of periodontal tissues that have been diminished by periodontal disease is the main goal of periodontal therapy. While conventional surgical therapy only offers limited potential towards ...

Eligibility Criteria

Inclusion

  • Males and females aged between 18 and 70 years.
  • Presence of at least one 1- or 2-wall intrabony periodontal defect.
  • Defect width at least 2 mm.
  • Defect depth at least 4 mm.
  • Defect located at a single rooted tooth or at the approximal site of a multi-rooted tooth if the tooth is not affected by a furcation involvement.
  • Written informed consent.
  • Subject must be judged healthy by the investigator at the time of surgery.
  • Subjects must have had a plaque index \< 0.8 at the end of the initial periodontal therapy.

Exclusion

  • Medical conditions required prolonged use of steroids.
  • Standard blood tests performed by the medical practitioner showing leukocyte dysfunction and deficiencies.
  • History of haemophilia, bleeding disorders, or cumarin therapy.
  • History of neoplastic disease requiring the use of chemotherapy.
  • History of radiation therapy of the head and neck.
  • History of renal failure or chronic renal diseases.
  • Chronic liver diseases.
  • Severe or uncontrolled metabolic bone disorders.
  • Uncontrolled endocrine disorders (including diabetes).
  • Current pregnancy at the time of recruitment.
  • Physical handicaps that would interfere with the ability to perform adequate oral hygiene.
  • Use of any investigational drug or device within the 90 day period prior to surgery on study day 0.
  • Alcoholism or chronical drug abuse.
  • Immuno-compromised patients (including HIV).
  • Smokers (occasional smoking is allowed).
  • Conditions or circumstances , in the opinion of the investigator, that could represent a general contra-indication for surgical procedures or would prevent completion of study participation or interfere with analysis of study results, such as a history of non-compliance, or unreliability.
  • Local inflammation.
  • Mucosal diseases (e.g. erosive lichen planus).
  • History of local radiation therapy.
  • Presence of oral lesions (e.g. ulceration, malignancy).
  • Inadequate oral hygiene or patient who is unmotivated for home care.
  • Teeth with untreated endodontic or cariologic problems.
  • Defects that during surgery show deviation from the inclusion criteria.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2012

Estimated Enrollment :

56 Patients enrolled

Trial Details

Trial ID

NCT00757159

Start Date

August 1 2008

End Date

January 1 2012

Last Update

January 18 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dresden University of Technology, Dental School, Department of Conservative Dentistry

Dresden, Germany, 01307